https://rectifypharma.com/ 2026-10-08T17:21:37+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-appoints-robert-hughes-as-executive-vice-president-drug-discovery-and-preclinical-development-and-xiaobing-li-as-chief-development-officer/ 2024-10-21T11:02:58+00:00 https://rectifypharma.com/press_release/rectify-pharmaceutical-announces-publication-of-trends-in-molecular-medicine-review-article-highlighting-the-therapeutic-potential-of-the-abc-transporter-superfamily/ 2024-10-21T11:03:16+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-expands-clinical-drug-development-expertise-with-board-and-sab-appointments/ 2024-10-21T11:03:57+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-appoints-sachiyo-minegishi-as-chief-operating-officer/ 2024-10-21T11:04:12+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-appoints-bharat-reddy-as-chief-business-officer/ 2024-10-21T11:04:36+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-appoints-pol-boudes-as-chief-medical-officer/ 2024-10-21T11:04:52+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-to-present-new-preclinical-data-at-the-american-association-for-the-study-of-liver-diseases-annual-meeting/ 2024-10-21T11:05:07+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-launches-with-100-million-series-a-financing-from-atlas-venture-omega-funds-forbion-and-longwood-fund/ 2024-11-05T10:17:11+00:00 https://rectifypharma.com/press_release/rectify-pharma-announces-positive-functional-modulator-rty-694-as-development-candidate-for-primary-sclerosing-cholangitis/ 2024-11-07T19:16:06+00:00 https://rectifypharma.com/press_release/rectify-pharma-to-host-virtual-rd-event-on-rty-694-for-primary-sclerosing-cholangitis-and-other-hepatobiliary-diseases-on-november-21-2024/ 2024-11-11T16:21:05+00:00 https://rectifypharma.com/press_release/rectify-pharma-presents-preclinical-data-supporting-development-of-lead-candidate/ 2024-11-18T09:06:02+00:00 https://rectifypharma.com/press_release/rectify-pharma-announces-publication-of-bsep-transporter-biophysical-characterization-in-communications-biology/ 2025-04-07T09:10:39+00:00 https://rectifypharma.com/press_release/rectify-pharma-to-share-preclinical-data-highlighting-progress-in-hepatobiliary-program-at-easl-2025/ 2025-04-22T13:45:59+00:00 https://rectifypharma.com/press_release/rectify-pharma-presents-translational-data-for-novel-positive-functional-modulator-demonstrating-improved-biliary-and-liver-health-at-easl-2025/ 2025-05-08T17:12:21+00:00 https://rectifypharma.com/press_release/rectify-pharma-to-present-translational-data-on-novel-approach-to-treat-chronic-kidney-disease-and-vascular-calcification-at-era-2025/ 2025-05-21T09:15:05+00:00 https://rectifypharma.com/press_release/rectify-pharma-presents-translational-data-demonstrating-improvements-in-kidney-function-and-reductions-in-vascular-calcification-at-era-2025/ 2025-06-05T21:58:14+00:00 https://rectifypharma.com/press_release/rectify-and-boehringer-ingelheim-collaborate-to-advance-first-in-class-treatments-for-chronic-kidney-disease/ 2025-12-22T08:19:05+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-to-present-preclinical-data-on-new-dual-targeted-abcb4-bsep-positive-functional-modulator-at-easl-2026/ 2026-05-13T08:38:20+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-presents-new-translational-data-at-easl-2026-supporting-rty-406-its-clinical-candidate-for-the-treatment-of-primary-sclerosing-cholangitis/ 2026-05-26T12:03:08+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-announces-appointment-of-constantine-chinoporos-as-executive-chairman/ 2026-07-15T09:09:05+00:00 https://rectifypharma.com/press_release/rectify-pharmaceuticals-presents-discovery-of-clinical-candidate-rty-406-a-novel-disease-modifying-therapy-for-the-treatment-of-psc-at-acs-fall-2026-meeting/ 2026-08-27T08:09:42+00:00